Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
25,354,708
-
Share change
-
-364,738
-
Total reported value
-
$507,648,169
-
Put/Call ratio
-
40%
-
Price per share
-
$20.02
-
Number of holders
-
122
-
Value change
-
-$14,529,623
-
Number of buys
-
69
-
Number of sells
-
55
Institutional Holders of ADAMAS PHARMACEUTICALS INC - COM (ADMS) as of Q3 2018
As of 30 Sep 2018,
ADAMAS PHARMACEUTICALS INC - COM (ADMS) was held by
122 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,354,708 shares.
The largest 10 holders included
Point72 Asset Management, L.P., Invesco Ltd., BlackRock Inc., STATE STREET CORP, MACQUARIE GROUP LTD, Broadfin Capital, LLC, Brenner West Capital Advisors, LP, Vanguard Group Inc, JANUS HENDERSON GROUP PLC, and Sectoral Asset Management Inc.
This page lists
122
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.